Sign in

Filings

Finds words inside filing documents. Searching Monopar Therapeutics's filings · 47 documents indexed.

8 documents · 16 matches

  1. MNPR Monopar Therapeutics 10-Q 2025-05-13

    Item 1 · Note 1. Nature of Business and Liquidity

    Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies
    2 matches in this document
  2. MNPR Monopar Therapeutics 10-Q 2026-05-14

    Item 1 · Note 1. Nature of Business and Liquidity

    Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies
    2 matches in this document
  3. MNPR Monopar Therapeutics 10-K/A 2026-04-01

    Item 15 · Note 1. Nature of Business and Liquidity

    Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies
    2 matches in this document
  4. MNPR Monopar Therapeutics 10-K 2026-03-27

    Item 15 · Note 1. Nature of Business and Liquidity

    Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies
    2 matches in this document
  5. MNPR Monopar Therapeutics 10-Q 2026-11-12

    Item 1 · Note 1. Nature of Business and Liquidity

    Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies
    2 matches in this document
  6. MNPR Monopar Therapeutics 10-Q 2026-08-12

    Item 1 · Note 1. Nature of Business and Liquidity

    Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies
    2 matches in this document
  7. MNPR Monopar Therapeutics 10-Q 2025-11-13

    Item 1 · Note 1. Nature of Business and Liquidity

    Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies
    2 matches in this document
  8. MNPR Monopar Therapeutics 10-Q 2025-08-12

    Item 1 · Note 1. Nature of Business and Liquidity

    Going Concern, which the Financial Accounting Standards Board (“FASB”) issued to provide guidance on determining when and how reporting companies
    2 matches in this document

Page 1 of 1 · 8 documents